| 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis (NCT01989468) | Novartis Pharmaceuticals | 2014-04-10 |
| Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (NCT04582084) | AryoGen Pharmed Co. | 2014-04-04 |
| Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort Study (NCT02232321) | Chinese University of Hong Kong | 2014-03-01 |
| Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis (NCT02024646) | Bausch Health Americas, Inc. | 2014-03-01 |
| A Phase 3 Clinical Study of KHK 4827 (NCT02052609) | Kyowa Kirin Co., Ltd. | 2014-02-01 |
| Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study (NCT01877668) | Pfizer | 2014-01-20 |
| To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA) (NCT02028169) | AbbVie | 2014-01-01 |
| A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta (NCT02019602) | UCB BIOSCIENCES, Inc. | 2014-01-01 |
| Distal Erosions and Nail Psoriasis (NCT02813720) | Hospices Civils de Lyon | 2013-11-01 |
| Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project (NCT02103361) | University of California, San Diego | 2013-11-01 |
| Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis (NCT01892436) | Novartis Pharmaceuticals | 2013-09-30 |
| Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis (NCT01925768) | Amgen | 2013-09-04 |
| Metformin in Psoriatic Arthritis (NCT02188654) | University of Alexandria | 2013-09-01 |
| Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors (NCT01882439) | Pfizer | 2013-08-01 |
| Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis (NCT01988103) | Amgen | 2013-07-09 |
| Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis (NCT01939132) | Fiechtner, Justus J., M.D., P.C. | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (NCT01692457) | Janssen Pharmaceutica | 2013-07-01 |
| Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis (NCT01860976) | Bristol-Myers Squibb | 2013-06-17 |
| Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept (NCT01901185) | Amgen | 2013-06-11 |
| Study in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) Patients to Evaluate Work Productivity Before and After the Start of Adalimumab Therapy in Daily Practice in Belgium (NCT01845818) | AbbVie | 2013-06-05 |
| Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (NCT02132234) | Jagiellonian University | 2013-06-01 |
| Employment and Arthritis: Making it Work (NCT01852851) | University of British Columbia | 2013-06-01 |
| to Translate and Validate the TOPAS TORONTO PSORIATIC SCREENING QUESTIONNAIRE)Into Spanish (NCT01891903) | Reumatologia Integral LTDA | 2013-05-01 |
| Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis (NCT01752634) | Novartis Pharmaceuticals | 2013-04-14 |
| The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA) Registry (NCT02530268) | CorEvitas | 2013-03-01 |
| The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis (NCT01818804) | Aalborg University Hospital | 2013-03-01 |
| Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice (NCT01768858) | AbbVie | 2013-02-05 |
| Functional Limitations Due To The Foot Involvement In Spondyloarthritis (NCT01833468) | Vakif Gureba Training and Research Hospital | 2013-02-01 |
| Interval Training Study in Psoriatic Arthritis (NCT02995460) | Norwegian University of Science and Technology | 2013-01-01 |
| Assessing Pain by the painDETECT Questionnaire (PDQ) (NCT06402396) | University Hospital Bispebjerg and Frederiksberg | 2013-01-01 |
| Korean College of Rheumatology Biologics and Targeted Therapy Registry (NCT01965132) | Seoul National University Hospital | 2012-12-01 |
| Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis (NCT01690299) | Amgen | 2012-10-01 |
| Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα (NCT01694264) | Seoul National University Hospital | 2012-09-01 |
| A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis (NCT01680159) | Tanabe Pharma Corporation | 2012-07-01 |
| PET/CT in Psoriatic Arthritis (NCT01654198) | University of Pennsylvania | 2012-07-01 |
| OTIS Cimzia Pregnancy Registry (NCT01797224) | University of California, San Diego | 2012-03-01 |
| Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (NCT01559038) | AbbVie (prior sponsor, Abbott) | 2012-02-16 |
| Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis (NCT02922192) | Biologics & Biosimilars Collective Intelligence Consortium | 2012-01-01 |
| Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis (NCT01474876) | AbbVie (prior sponsor, Abbott) | 2011-11-01 |
| AMG 827 in Subjects With Psoriatic Arthritis (NCT01516957) | Bausch Health Americas, Inc. | 2011-10-01 |
| Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) (NCT01392326) | Novartis Pharmaceuticals | 2011-09-01 |
| Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)? (NCT02164214) | Assistance Publique Hopitaux De Marseille | 2011-09-01 |
| Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment (NCT01316224) | AbbVie (prior sponsor, Abbott) | 2011-04-01 |
| Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab (NCT01282372) | AbbVie (prior sponsor, Abbott) | 2011-03-01 |
| Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab (NCT01273519) | AbbVie (prior sponsor, Abbott) | 2011-01-01 |
| Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA) (NCT01307423) | Amgen | 2010-12-09 |
| PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (NCT01212770) | Amgen | 2010-09-30 |
| PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (NCT01212757) | Amgen | 2010-09-27 |
| Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice (NCT01147874) | Pfizer | 2010-08-01 |
| Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (NCT01172938) | Amgen | 2010-06-02 |
| Exploratory Study on Quality of Life in Patient With Moderate Psoriasis and Moderate Psoriatic Arthritis (NCT01139918) | Innovaderm Research Inc. | 2010-06-01 |
| Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis (NCT01169844) | Novartis Pharmaceuticals | 2010-06-01 |
| National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study (NCT01123265) | University of Rochester | 2010-06-01 |
| T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade (NCT01060098) | Imperial College London | 2010-04-01 |
| A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis (NCT00963313) | Dr. FRANCISCO J. BLANCO-GARCIA | 2010-03-01 |
| Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA) (NCT01198509) | NYU Langone Health | 2010-01-01 |
| Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis (NCT00809614) | Novartis Pharmaceuticals | 2009-03-01 |
| 99mTc-anti-TNF-alpha Scintigraphy in the Evaluation of Inflammatory Processes Activity (NCT02134613) | Universidade Federal do Rio de Janeiro | 2009-01-01 |
| Study Evaluating Epidemiology of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in Australia (NCT00751387) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-11-01 |
| Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs (NCT01083693) | Abbott | 2008-09-01 |
| Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis (NCT00884468) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-05-01 |
| TIght COntrol of Psoriatic Arthritis (NCT01106079) | Julia Brown | 2008-05-01 |
| Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment (NCT00902005) | Revmatismesykehuset AS | 2008-04-01 |
| PsoBest - The German Psoriasis Registry (NCT01848028) | Universitätsklinikum Hamburg-Eppendorf | 2008-01-01 |
| Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care (NCT01163916) | Abbott | 2008-01-01 |
| Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis (NCT00534313) | Bristol-Myers Squibb | 2007-11-01 |
| Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy (NCT00517101) | Tel-Aviv Sourasky Medical Center | 2007-09-01 |
| Surveillance of Humira Injection in Korean Patients (NCT01083121) | AbbVie (prior sponsor, Abbott) | 2007-04-01 |
| Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis (NCT00456092) | Amgen | 2007-03-05 |
| Centocor Microarray Study of Patients (NCT00462072) | University of Rochester | 2007-03-01 |
| Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic Arthritis (NCT00580632) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| Rituxan With or Without Methotrexate in Psoriatic Arthritis (NCT00509678) | Swedish Medical Center | 2006-12-01 |
| HUmira in Psoriatic Arthritis (NCT01465438) | Glostrup University Hospital, Copenhagen | 2006-11-01 |
| A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM) (NCT00427362) | Abbott | 2006-05-01 |
| Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis (NCT00432406) | Chinese University of Hong Kong | 2006-05-01 |
| Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs (NCT03496831) | Simon Krabbe | 2006-01-01 |
| Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis (NCT00245960) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-12-27 |
| An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis (NCT00267956) | Centocor, Inc. | 2005-12-01 |
| REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®) (NCT00127842) | Amgen | 2005-08-01 |
| Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice (NCT01111240) | AbbVie (prior sponsor, Abbott) | 2005-08-01 |
| Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA) (NCT00235885) | Abbott | 2005-07-01 |
| Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment (NCT00451243) | National Taiwan University Hospital | 2005-01-01 |
| TNFalfa Blocking Treatment of Spondylarthropathies (NCT00133315) | Hvidovre University Hospital | 2004-09-01 |
| A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) (NCT01078558) | AbbVie (prior sponsor, Abbott) | 2004-05-13 |
| A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis (NCT00659412) | Astellas Pharma Inc | 2003-09-01 |
| Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis (NCT00195689) | Abbott | 2003-08-01 |
| Impact of Literacy Level on Patient Education and Health Among People With Arthritis (NCT00023205) | Brigham and Women's Hospital | 2002-11-01 |
| Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis (NCT00317499) | Amgen | 2000-04-01 |
| Study of Psoriatic Arthritis (NCT00001420) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1995-03-01 |
| Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine (NCT01078610) | Abbott | |
| Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis (NCT00051662) | XOMA (US) LLC | |